ARCHIVES

Arzerra Promising For Heavily Pre-Treated CLL Patients

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Scientists Falsified Research, ORI Says

July 5, 1996

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

In Brief: No End Of The Year Hassle His Time – NCI Full Appropriation for FY 1977 Released

November 19, 1976